title: Hepatic injury due to troglitazone.
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-9151, USA.
authors.forename: A H
authors.initials: AH
authors.lastname: Malik
authors.forename: P
authors.initials: P
authors.lastname: Prasad
authors.forename: M H
authors.initials: MH
authors.lastname: Saboorian
authors.forename: D L
authors.initials: DL
authors.lastname: Thiele
authors.forename: P F
authors.initials: PF
authors.lastname: Malet
mesh_terms: D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D002839:Chromans / Q000009:adverse effects* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D008875:Middle Aged; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use; D045162:Thiazolidinediones; D000077288:Troglitazone
chemical_list: D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone